NCT07150117 2026-03-12
CYCLE-CIPN
University of Alberta
Phase NA Recruiting
Clinical Trials
14 trialsNCT06657157 2026-02-24
P-EVOLUTION
Comprehensive Cancer Center Munich (CCCM)
Recruiting
NCT06807294 2026-01-29
Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)
Dana-Farber Cancer Institute
Phase NA Recruiting
NCT06400849 2025-12-23
ARIANE
Centre Antoine Lacassagne
Phase NA Recruiting
NCT05582551 2025-12-22
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
Washington University School of Medicine
Phase NA Recruiting
NCT07285356 2025-12-16
GLOX-PEN
AC Camargo Cancer Center
Phase NA Recruiting
NCT05357469 2025-11-06
Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults With Cancer: A Two Arm Pilot Study
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT07025005 2025-11-04
VRd MM Fibrate
Tanta University
Phase 4 Recruiting
NCT05104736 2025-09-19
PT-112 in Subjects With Thymoma and Thymic Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT07160270 2025-09-08
This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenström's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process
Rigshospitalet, Denmark
Recruiting
NCT07019233 2025-06-13
A Study of the Effect of Real-time Pressure Controllers on Subjective and Objective Symptoms of Peripheral Neuropathy Induced by Albumin Paclitaxel
Tianjin Medical University Cancer Institute and Hospital
Phase NA Recruiting
NCT05404230 2025-03-28
OxaNeuro
Vejle Hospital
Phase NA Recruiting
NCT05990426 2024-12-18
FAST
Northwestern University
Phase NA Recruiting
NCT05777499 2024-10-23
MUSICS
University College, London
Phase NA Recruiting